Nancy Wysenski - 15 Jul 2026 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Reporting relationship: Director
Issuer ticker: CYTK
Reported as of: 15 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jul 2026, 16:35:53 UTC
Prior SEC filing: 27 May 2026
Source filing: View source filing
Reporting owner signature: /s/ John Faurescu, attorney-in-fact for Ms. Wysenski

Key filing fact

Nancy Wysenski filed Form 4 for CYTOKINETICS INC (CYTK) on 16 Jul 2026.

Key facts

This page summarizes Nancy Wysenski's Form 4 filing for CYTOKINETICS INC (CYTK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Jul 2026, 16:35.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001294596 Primary reporting owner

Shares, units, or other non-derivative securities reported in this filing.

CYTK transaction

Award

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant.